Scabies is a widespread issue in prisons due to overcrowded living conditions and limited
healthcare resources. A recent study published in the Journal of Infection and Public Health …

There is a critical need for advancements in disease management strategies for wildlife, but
free‐living animals pose numerous challenges that can hinder progress. Most disease …

Background Ivermectin, an effective treatment for scabies, is not licensed for children
weighing< 15 kg. Pharmacokinetic modelling has shown a 3 mg dose in young children (2 …

Scabies is an itchy skin disease caused by the burrowing mite Sarcoptes scabiei. During
their lifespan, the female mites invade the stratum corneum and create tunnels, in which they …

Recently, scabies was included in the WHO roadmap for neglected tropical diseases 2021–
2030. Till now, ivermectin is the only available oral drug that is currently approved for …

Background Sarcoptic mange is a serious animal welfare concern in bare-nosed wombats
(Vombatus ursinus). Fluralaner (Bravecto®) is a novel acaricide that has recently been …

Sarcoptic mange (etiological agent Sarcoptes scabiei) is among the most important parasitic
diseases of some marsupial species and has been an emerging disease of koalas, causing …

Simparica TRIO®, a canine endectocide manufactured by Zoetis, contains sarolaner,
moxidectin, and pyrantel pamoate salt in an orally administered chewable tablet. These …

Sarcoptes scabiei, the microscopic burrowing mite responsible for sarcoptic mange, affects
approximately 150 mammalian species across the world. In Australia, this disease is …